Healthcare Consulting Services Market by Service Type (IT & Digital Transformation, Strategy, Marketing, Commercialization, Financial), End User (Pharma & Biotech, Hospital, ASCs, Payers, Medical Device Companies, Government), Region- Global Forecast to 2030

1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 MARKET SCOPE 26 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 26 1.3.2 INCLUSIONS AND EXCLUSIONS 27 1.3.3 YEARS CONSIDERED 28 1.4 CURRENCY CONSIDERED 28 1.5 STAKEHOLDERS 29 2 RESEARCH METHODOLOGY 30 2.1 RESEARCH DATA 30 2.1.1 SECONDARY DATA 31 2.1.1.1 Key data from secondary sources 31 2.1.2 PRIMARY DATA 32 2.1.2.1 Key data from primary sources 33 2.1.2.2 Breakdown of primary interviews 34 2.2 MARKET SIZE ESTIMATION 35 2.2.1 SUPPLY-SIDE ANALYSIS 36 2.2.2 BOTTOM-UP APPROACH 38 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 39 2.2.4 GROWTH FORECAST 39 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 43 2.4 RESEARCH ASSUMPTIONS 44 2.4.1 PARAMETRIC ASSUMPTIONS 44 2.4.2 STUDY-RELATED ASSUMPTIONS 44 2.5 RESEARCH LIMITATIONS 45 2.5.1 METHODOLOGY-RELATED LIMITATIONS 45 2.5.2 SCOPE-RELATED LIMITATIONS 45 2.6 RISK ANALYSIS 45 3 EXECUTIVE SUMMARY 46 4 PREMIUM INSIGHTS 49 4.1 HEALTHCARE CONSULTING SERVICES MARKET OVERVIEW 49 4.2 ASIA PACIFIC HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY AND END USER 50 4.3 HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL GROWTH OPPORTUNITIES 51 4.4 HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL MIX 51 4.5 HEALTHCARE CONSULTING SERVICES MARKET: EMERGING VS. DEVELOPED MARKETS 52 5 MARKET OVERVIEW 53 5.1 INTRODUCTION 53 5.2 MARKET DYNAMICS 53 5.2.1 DRIVERS 54 5.2.1.1 Growing trend of digitization 54 5.2.1.2 Increasing adoption of big data analytics, IoT, and cloud deployment 55 5.2.1.3 Changing healthcare landscape 56 5.2.1.4 Rising government support for HCIT solutions 57 5.2.1.5 Emergence of new business models 57 5.2.1.6 Growing incidence of chronic and infectious diseases 58 5.2.1.7 Need for data security 59 5.2.1.8 Increasing pressure to reduce healthcare costs 60 5.2.2 RESTRAINTS 60 5.2.2.1 Data confidentiality concerns 60 5.2.2.2 Hidden costs of consulting services 61 5.2.3 OPPORTUNITIES 61 5.2.3.1 Rising trend of consolidation 61 5.2.3.2 Opportunities in emerging markets 62 5.2.3.3 Consistent rise in mergers and acquisitions 62 5.2.4 CHALLENGES 63 5.2.4.1 Rising number of multi-sourcing approaches 63 5.3 INDUSTRY TRENDS 63 5.3.1 DIGITAL TRANSFORMATION IN HEALTHCARE 63 5.3.2 SHIFT TOWARD VALUE-BASED CARE 63 5.3.3 FOCUS ON PATIENT-CENTRIC CARE 63 5.3.4 RISING IMPORTANCE OF SOCIAL DETERMINANTS OF HEALTH 64 5.3.5 EXPANDING USE OF DATA ANALYTICS 64 5.3.6 GROWTH OF PRECISION MEDICINE 64 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65 5.5 INDICATIVE PRICING ANALYSIS 65 5.5.1 INDICATIVE PRICING ANALYSIS, BY TYPE OF SERVICE 66 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION 66 5.6 VALUE CHAIN ANALYSIS 67 5.7 ECOSYSTEM ANALYSIS 68 5.8 INVESTMENT AND FUNDING SCENARIO 69 5.9 TECHNOLOGY ANALYSIS 70 5.9.1 KEY TECHNOLOGIES 71 5.9.1.1 Machine learning 71 5.9.1.2 Artificial intelligence 71 5.9.1.3 Cloud computing 71 5.9.1.4 Big data and advanced analytics 71 5.9.2 COMPLEMENTARY TECHNOLOGIES 72 5.9.2.1 Robotic Process Automation (RPA) 72 5.9.2.2 Natural Language Processing (NLP) 72 5.9.3 ADJACENT TECHNOLOGIES 72 5.9.3.1 Blockchain 72 5.9.3.2 Internet of Things (IoT) 72 5.10 KEY CONFERENCES AND EVENTS, 2025–2026 73 5.11 CASE STUDY ANALYSIS 74 5.11.1 ENHANCED PATIENT EXPERIENCE WITH PAPERLESS PROCESS 74 5.11.2 ADVANCED CLOUD SOLUTION TO IMPROVE HUMAN CAPITAL MANAGEMENT CAPABILITIES 74 5.11.3 DEVELOPMENT OF RISK MANAGEMENT PLANS FOR EFFECTIVE TREATMENT 75 5.12 REGULATORY LANDSCAPE 76 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 5.12.2 REGULATORY ANALYSIS 79 5.12.2.1 North America 79 5.12.2.2 Europe 80 5.12.2.3 Asia Pacific 80 5.12.2.4 Middle East & Africa 81 5.12.2.5 Latin America 81 5.13 PORTER’S FIVE FORCES ANALYSIS 81 5.13.1 BARGAINING POWER OF SUPPLIERS 82 5.13.2 BARGAINING POWER OF BUYERS 83 5.13.3 THREAT OF NEW ENTRANTS 83 5.13.4 THREAT OF SUBSTITUTES 83 5.13.5 INTENSITY OF COMPETITIVE RIVALRY 83 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 84 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 84 5.14.2 BUYING CRITERIA 85 5.15 BUSINESS MODELS 85 5.16 IMPACT OF 2025 US TARIFF 86 5.16.1 INTRODUCTION 86 5.16.2 KEY TARIFF RATES 87 5.16.3 PRICE IMPACT ANALYSIS 87 5.16.4 IMPACT ON COUNTRY/REGION 88 5.16.4.1 US 88 5.16.4.2 Europe 88 5.16.4.3 Asia Pacific 89 5.16.5 IMPACT ON END-USE INDUSTRIES 89   6 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE 91 6.1 INTRODUCTION 92 6.2 IT/DIGITAL TRANSFORMATION CONSULTING 93 6.2.1 RISING DEMAND FOR MODERNIZATION AND VALUE-BASED CARE DELIVERY TO AID GROWTH 93 6.3 STRATEGY CONSULTING 94 6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS TO FACILITATE GROWTH 94 6.4 OPERATIONS CONSULTING 95 6.4.1 TRANSITION FROM FEE-FOR-SERVICE TO COORDINATED CARE MODEL TO SUSTAIN GROWTH 95 6.5 FINANCIAL CONSULTING 97 6.5.1 RISING NEED FOR OPTIMIZED REVENUE CYCLE MANAGEMENT TO STIMULATE GROWTH 97 6.6 HR & TALENT CONSULTING 98 6.6.1 ONGOING SHORTAGE OF HEALTHCARE PROFESSIONALS TO PROMOTE GROWTH 98 6.7 MARKETING, SALES, AND COMMERCIALIZATION CONSULTING 99 6.7.1 INNOVATIONS IN DRUG DEVELOPMENT AND MEDICAL TECHNOLOGY TO DRIVE MARKET 99 6.8 REGULATORY & COMPLIANCE 100 6.8.1 RAPID ADOPTION OF DIGITAL HEALTH TECHNOLOGIES TO AUGMENT GROWTH 100 6.9 R&D CONSULTING 101 6.9.1 GROWING DEMAND FOR NEW DRUGS TO BOOST MARKET 101 6.10 PUBLIC HEALTH CONSULTING 102 6.10.1 INCREASING INVESTMENTS IN PUBLIC HEALTH INFRASTRUCTURE TO FOSTER GROWTH 102 6.11 OTHER CONSULTING SERVICES 103 7 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER 105 7.1 INTRODUCTION 106 7.2 GOVERNMENT BODIES 106 7.2.1 GROWING INVESTMENTS IN MODERNIZING DIGITAL AND TECHNOLOGY INFRASTRUCTURE TO FUEL MARKET 106 7.3 HEALTHCARE PROVIDERS 108 7.3.1 HOSPITALS 109 7.3.1.1 Growing need for telehealth and remote care to propel market 109 7.3.2 AMBULATORY CARE CENTERS 111 7.3.2.1 Rising demand for convenient and patient-centered services to bolster growth 111 7.3.3 LONG-TERM CARE FACILITIES 112 7.3.3.1 Booming geriatric population to contribute to growth 112 7.3.4 DIAGNOSTIC & IMAGING CENTERS 113 7.3.4.1 Rising global demand for early disease detection, precision diagnostics, and outpatient imaging services to favor growth 113 7.3.5 OTHER HEALTHCARE PROVIDERS 114 7.4 HEALTH INSURANCE PAYERS 115 7.4.1 PRIVATE PAYERS 116 7.4.1.1 Need for regulatory compliance to encourage growth 116 7.4.2 PUBLIC PAYERS 117 7.4.2.1 Growing digital transformation initiatives to boost market 117 7.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 118 7.5.1 EVOLVING LIFE SCIENCES LANDSCAPE TO SPUR GROWTH 118 7.6 MEDICAL DEVICE COMPANIES 119 7.6.1 GROWING FOCUS OF MEDICAL DEVICE COMPANIES ON CUTTING-EDGE TECHNOLOGY TO DRIVE MARKET 119 7.7 OTHER END USERS 120 8 HEALTHCARE CONSULTING SERVICES MARKET, BY REGION 122 8.1 INTRODUCTION 123 8.2 NORTH AMERICA 123 8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 125 8.2.2 US 127 8.2.2.1 Advanced infrastructure and high healthcare spending to augment growth 127 8.2.3 CANADA 130 8.2.3.1 Shift toward technology-driven integrated healthcare model to spur growth 130 8.3 EUROPE 133 8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 133 8.3.2 GERMANY 136 8.3.2.1 Increasing emphasis on electronic documentation and compliance to spur growth 136 8.3.3 UK 139 8.3.3.1 Need for sectoral restructuring to accelerate growth 139 8.3.4 FRANCE 142 8.3.4.1 Need to ensure interoperability and compatibility among healthcare IT systems to aid growth 142 8.3.5 ITALY 145 8.3.5.1 Expansion of digital health sector to support growth 145 8.3.6 SPAIN 148 8.3.6.1 Growing digitization of healthcare systems to boost market 148 8.3.7 REST OF EUROPE 150 8.4 ASIA PACIFIC 152 8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 153 8.4.2 JAPAN 157 8.4.2.1 Increasing adoption of information technology in medical care and home nursing to promote growth 157   8.4.3 CHINA 160 8.4.3.1 Favorable government initiatives to bolster growth 160 8.4.4 INDIA 163 8.4.4.1 Growing adoption of connected healthcare ecosystem to boost market 163 8.4.5 REST OF ASIA PACIFIC 166 8.5 LATIN AMERICA 168 8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 169 8.5.2 BRAZIL 171 8.5.2.1 Ongoing efforts to modernize healthcare infrastructure to promote growth 171 8.5.3 MEXICO 174 8.5.3.1 Rising healthcare costs to contribute to growth 174 8.5.4 REST OF LATIN AMERICA 176 8.6 MIDDLE EAST & AFRICA 178 8.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 179 8.6.2 GCC COUNTRIES 181 8.6.2.1 Increasing investments in healthcare infrastructure to contribute to growth 181 8.6.3 REST OF MIDDLE EAST & AFRICA 184 9 COMPETITIVE LANDSCAPE 187 9.1 OVERVIEW 187 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 187 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET 187 9.3 REVENUE ANALYSIS, 2020–2024 190 9.4 MARKET SHARE ANALYSIS, 2024 191 9.5 COMPANY VALUATION AND FINANCIAL METRICS 193 9.6 BRAND/SOFTWARE COMPARISON 194 9.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 195 9.7.1 STARS 195 9.7.2 EMERGING LEADERS 195 9.7.3 PERVASIVE PLAYERS 195 9.7.4 PARTICIPANTS 195 9.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 197 9.7.5.1 Company footprint 197 9.7.5.2 Region footprint 198 9.7.5.3 Type of service footprint 199 9.7.5.4 End-user footprint 200 9.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 201 9.8.1 PROGRESSIVE COMPANIES 201 9.8.2 RESPONSIVE COMPANIES 201 9.8.3 DYNAMIC COMPANIES 201 9.8.4 STARTING BLOCKS 201 9.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 203 9.8.5.1 Detailed list of key startups/SMEs 203 9.8.5.2 Competitive benchmarking of key startups/SMEs 203 9.9 COMPETITIVE SCENARIO 204 9.9.1 PRODUCT LAUNCHES 204 9.9.2 DEALS 204 9.9.3 EXPANSIONS 205 9.9.4 OTHER DEVELOPMENTS 206 10 COMPLNY PROFILE 207 10.1 KEY PLAYERS 207 10.1.1 ACCENTURE 207 10.1.1.1 Business overview 207 10.1.1.2 Products/Services/Solutions offered 208 10.1.1.3 Recent developments 209 10.1.1.3.1 Deals 209 10.1.1.4 MnM view 210 10.1.1.4.1 Key strengths 210 10.1.1.4.2 Strategic choices 210 10.1.1.4.3 Weaknesses and competitive threats 211 10.1.2 COGNIZANT 212 10.1.2.1 Business overview 212 10.1.2.2 Products/Services/Solutions offered 213 10.1.2.3 Recent developments 214 10.1.2.3.1 Deals 214 10.1.2.3.2 Expansions 215 10.1.2.4 MnM view 215 10.1.2.4.1 Key strengths 215 10.1.2.4.2 Strategic choices 215 10.1.2.4.3 Weaknesses and competitive threats 215 10.1.3 DELOITTE 216 10.1.3.1 Business overview 216 10.1.3.2 Products/Services/Solutions offered 216 10.1.3.3 Recent developments 217 10.1.3.3.1 Product launches 217 10.1.3.3.2 Deals 217 10.1.3.4 MnM view 218 10.1.3.4.1 Key strengths 218 10.1.3.4.2 Strategic choices 218 10.1.3.4.3 Weaknesses and competitive threats 218 10.1.4 MCKINSEY & COMPANY 219 10.1.4.1 Business overview 219 10.1.4.2 Products/Services/Solutions offered 219 10.1.4.3 Recent developments 220 10.1.4.3.1 Product launches 220 10.1.4.4 Recent developments 221 10.1.4.4.1 Deals 221 10.1.4.5 MnM view 221 10.1.4.5.1 Key strengths 221 10.1.4.5.2 Strategic choices 221 10.1.4.5.3 Weaknesses and competitive threats 222 10.1.5 BOSTON CONSULTING GROUP 223 10.1.5.1 Business overview 223 10.1.5.2 Products/Services/Solutions offered 223 10.1.5.3 Recent developments 224 10.1.5.3.1 Deals 224 10.1.5.4 MnM view 224 10.1.5.4.1 Key strengths 224 10.1.5.4.2 Strategic choices 225 10.1.5.4.3 Weaknesses and competitive threats 225 10.1.6 PWC 226 10.1.6.1 Business overview 226 10.1.6.2 Products/Services/Solutions offered 226 10.1.6.3 Recent developments 227 10.1.6.3.1 Deals 227 10.1.7 EY 228 10.1.7.1 Business overview 228 10.1.7.2 Products/Services/Solutions offered 228 10.1.7.3 Recent developments 229 10.1.7.3.1 Product launches 229 10.1.8 HURON CONSULTING GROUP INC. 230 10.1.8.1 Business overview 230 10.1.8.2 Products/Services/Solutions offered 231 10.1.8.3 Recent developments 232 10.1.8.3.1 Deals 232 10.1.9 KPMG 233 10.1.9.1 Business overview 233 10.1.9.2 Products/Services/Solutions offered 234 10.1.9.3 Recent developments 236 10.1.9.3.1 Product launches 236 10.1.9.3.2 DEALS 237   10.1.10 BAIN & COMPANY, INC. 238 10.1.10.1 Business overview 238 10.1.10.2 Products/Services/Solutions offered 238 10.1.10.3 Recent developments 239 10.1.10.3.1 Deals 239 10.1.11 IQVIA INC. 241 10.1.11.1 Business overview 241 10.1.11.2 Products/Services/Solutions offered 242 10.1.11.3 Recent developments 244 10.1.11.3.1 Product launches 244 10.1.11.4 Recent developments 244 10.1.11.4.1 Deals 244 10.1.12 L.E.K. CONSULTING 246 10.1.12.1 Business overview 246 10.1.12.2 Products/Services/Solutions offered 246 10.1.12.3 Recent developments 247 10.1.12.3.1 Deals 247 10.1.12.3.2 Expansions 248 10.1.13 NTT DATA, INC. 249 10.1.13.1 Business overview 249 10.1.13.2 Products/Services/Solutions offered 250 10.1.13.3 Recent developments 251 10.1.13.3.1 Product launches 251 10.1.13.3.2 Deals 251 10.1.14 OLIVER WYMAN, LLC 253 10.1.14.1 Business overview 253 10.1.14.2 Products/Services/Solutions offered 253 10.1.14.3 Recent developments 254 10.1.14.3.1 Product launches 254 10.1.14.3.2 Deals 255 10.1.15 SIMON-KUCHER & PARTNERS 256 10.1.15.1 Business overview 256 10.1.15.2 Products/Services/Solutions offered 256 10.1.16 IBM 258 10.1.16.1 Business overview 258 10.1.16.2 Products/Services/Solutions offered 259 10.1.16.3 Recent developments 261 10.1.16.3.1 Product launches 261 10.1.16.3.2 Deals 262 10.1.17 CLEARVIEW HEALTHCARE PARTNERS 263 10.1.17.1 Business overview 263 10.1.17.2 Products/Services/Solutions offered 263 10.1.17.3 Recent developments 264 10.1.17.3.1 Other developments 264 10.1.18 ALVAREZ & MARSAL HOLDINGS, LLC 265 10.1.18.1 Business overview 265 10.1.18.2 Products offered 265 10.1.18.3 Recent developments 266 10.1.18.3.1 Product launches 266 10.1.19 ZS ASSOCIATES 267 10.1.19.1 Business overview 267 10.1.19.2 Products/Services/Solutions offered 267 10.1.19.3 Recent developments 268 10.1.19.3.1 Product launches 268 10.1.19.3.2 Deals 269 10.1.20 CHARTIS 270 10.1.20.1 Business overview 270 10.1.20.2 Products/Services/Solutions offered 270 10.1.20.3 Recent developments 271 10.1.20.3.1 Deals 271 10.2 OTHER PLAYERS 272 10.2.1 QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED 272 10.2.2 LUCID HEALTH CONSULTING 273 10.2.3 BLUE MATTER CONSULTING 274 10.2.4 ISOS CONSULTANCY SERVICES PVT. LTD. 275 10.2.5 BACK BAY LIFE SCIENCE ADVISORS 276 11 APPENDIX 277 11.1 DISCUSSION GUIDE 277 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 281 11.3 CUSTOMIZATION OPTIONS 283 11.4 RELATED REPORTS 283 11.5 AUTHOR DETAILS 284

TABLE 1 HEALTHCARE CONSULTING SERVICES MARKET: INCLUSIONS AND EXCLUSIONS 27 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021–2024 28 TABLE 3 FACTOR ANALYSIS 40 TABLE 4 HEALTHCARE CONSULTING SERVICES MARKET: RISK ANALYSIS 45 TABLE 5 HEALTHCARE CONSULTING SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 54 TABLE 6 INDICATIVE PRICING ANALYSIS FOR HEALTHCARE CONSULTING SERVICES, BY TYPE, 2024 66 TABLE 7 HEALTHCARE CONSULTING SERVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 69 TABLE 8 HEALTHCARE CONSULTING SERVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 73 TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 14 HEALTHCARE CONSULTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 81 TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 84 TABLE 16 KEY BUYING CRITERIA FOR TOP THREE END USERS 85 TABLE 17 US ADJUSTED RECIPROCAL TARIFF RATES 87 TABLE 18 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 92 TABLE 19 KEY PLAYERS PROVIDING IT/DIGITAL TRANSFORMATION CONSULTING SERVICES 93 TABLE 20 IT/DIGITAL TRANSFORMATION CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 94 TABLE 21 KEY PLAYERS PROVIDING STRATEGY CONSULTING SERVICES 95 TABLE 22 STRATEGY CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 23 KEY PLAYERS PROVIDING OPERATIONS CONSULTING SERVICES 96 TABLE 24 OPERATIONS CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 25 KEY PLAYERS PROVIDING FINANCIAL CONSULTING SERVICES 97 TABLE 26 FINANCIAL CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 98 TABLE 27 KEY PLAYERS PROVIDING HR & TALENT CONSULTING SERVICES 99 TABLE 28 HR & TALENT CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 29 KEY PLAYERS PROVIDING MARKETING, SALES, AND COMMERCIALIZATION CONSULTING SERVICES 100 TABLE 30 MARKETING, SALES & COMMERCIALIZATION CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 100 TABLE 31 KEY PLAYERS PROVIDING REGULATORY & COMPLIANCE CONSULTING SERVICES 101 TABLE 32 REGULATORY & COMPLIANCE CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 101 TABLE 33 KEY PLAYERS PROVIDING R&D CONSULTING SERVICES 102 TABLE 34 R&D CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 35 KEY PLAYERS PROVIDING PUBLIC HEALTH CONSULTING SERVICES 103 TABLE 36 PUBLIC HEALTH CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 37 KEY PLAYERS PROVIDING OTHER CONSULTING SERVICES 104 TABLE 38 OTHER CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 39 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 106 TABLE 40 HEALTHCARE CONSULTING SERVICES MARKET FOR GOVERNMENT BODIES, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 41 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 109 TABLE 42 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 43 HEALTHCARE CONSULTING SERVICES MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 44 HEALTHCARE CONSULTING SERVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 45 HEALTHCARE CONSULTING SERVICES MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 46 HEALTHCARE CONSULTING SERVICES MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 47 HEALTHCARE CONSULTING SERVICES MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 48 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 115 TABLE 49 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 50 HEALTHCARE CONSULTING SERVICES MARKET FOR PRIVATE PAYERS, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 51 HEALTHCARE CONSULTING SERVICES MARKET FOR PUBLIC PAYERS, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 52 HEALTHCARE CONSULTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 53 HEALTHCARE CONSULTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 54 HEALTHCARE CONSULTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 55 HEALTHCARE CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 56 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 57 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 126 TABLE 58 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 126 TABLE 59 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 60 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 127 TABLE 61 US: KEY MACROECONOMIC INDICATORS 128 TABLE 62 US: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 129 TABLE 63 US: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 64 US: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 65 US: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 130 TABLE 66 CANADA: KEY MACROECONOMIC INDICATORS 131 TABLE 67 CANADA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 131 TABLE 68 CANADA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 132 TABLE 69 CANADA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 132 TABLE 70 CANADA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 133 TABLE 71 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 72 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 135 TABLE 73 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 135 TABLE 74 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 75 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 136 TABLE 76 GERMANY: KEY MACROECONOMIC INDICATORS 137 TABLE 77 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 137 TABLE 78 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 79 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 138 TABLE 80 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 139 TABLE 81 UK: KEY MACROECONOMIC INDICATORS 140 TABLE 82 UK: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 141 TABLE 83 UK: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 141 TABLE 84 UK: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 85 UK: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 142 TABLE 86 FRANCE: KEY MACROECONOMIC INDICATORS 143 TABLE 87 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 143 TABLE 88 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 144 TABLE 89 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 90 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 145 TABLE 91 ITALY: KEY MACROECONOMIC INDICATORS 146 TABLE 92 ITALY: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 146 TABLE 93 ITALY: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 94 ITALY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 147 TABLE 95 ITALY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 148 TABLE 96 SPAIN: KEY MACROECONOMIC INDICATORS 148 TABLE 97 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 149 TABLE 98 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 149 TABLE 99 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 100 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 150 TABLE 101 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 151 TABLE 102 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 103 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 104 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 152 TABLE 105 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 106 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 155 TABLE 107 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 108 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 109 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 157 TABLE 110 JAPAN: KEY MACROECONOMIC INDICATORS 158 TABLE 111 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 158 TABLE 112 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 113 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 114 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 160 TABLE 115 CHINA: KEY MACROECONOMIC INDICATORS 161 TABLE 116 CHINA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 161 TABLE 117 CHINA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 118 CHINA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 119 CHINA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 163 TABLE 120 INDIA: KEY MACROECONOMIC INDICATORS 164 TABLE 121 INDIA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 164 TABLE 122 INDIA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 123 INDIA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 124 INDIA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 166 TABLE 125 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 167 TABLE 126 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 127 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 128 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 168 TABLE 129 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 130 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 170 TABLE 131 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 132 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 133 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 171 TABLE 134 BRAZIL: KEY MACROECONOMIC INDICATORS 172 TABLE 135 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 172 TABLE 136 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 137 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 138 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 174 TABLE 139 MEXICO: KEY MACROECONOMIC INDICATORS 174 TABLE 140 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 175 TABLE 141 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 142 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 143 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 176 TABLE 144 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 177 TABLE 145 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 177 TABLE 146 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 147 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 178 TABLE 148 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 149 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 180 TABLE 150 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 151 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 152 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 181 TABLE 153 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 182 TABLE 154 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 155 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 156 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 184 TABLE 157 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION) 185 TABLE 158 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 159 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 160 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 186 TABLE 161 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET, JANUARY 2022–MAY 2025 187 TABLE 162 HEALTHCARE CONSULTING SERVICES MARKET: DEGREE OF COMPETITION 191 TABLE 163 HEALTHCARE CONSULTING SERVICES MARKET: REGION FOOTPRINT, 2024 198 TABLE 164 HEALTHCARE CONSULTING SERVICES MARKET: TYPE OF SERVICE FOOTPRINT, 2024 199 TABLE 165 HEALTHCARE CONSULTING SERVICES MARKET: END-USER FOOTPRINT, 2024 200 TABLE 166 HEALTHCARE CONSULTING SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 203 TABLE 167 HEALTHCARE CONSULTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 203 TABLE 168 HEALTHCARE CONSULTING SERVICES MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 204 TABLE 169 HEALTHCARE CONSULTING SERVICES MARKET: DEALS, JANUARY 2022–MAY 2025 204 TABLE 170 HEALTHCARE CONSULTING SERVICES MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 205 TABLE 171 HEALTHCARE CONSULTING SERVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 206 TABLE 172 ACCENTURE: COMPANY OVERVIEW 207 TABLE 173 ACCENTURE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 208 TABLE 174 ACCENTURE: DEALS, JANUARY 2022–MAY 2025 209 TABLE 175 COGNIZANT: COMPANY OVERVIEW 212 TABLE 176 COGNIZANT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 213 TABLE 177 COGNIZANT: DEALS, JANUARY 2022–MAY 2025 214 TABLE 178 COGNIZANT: EXPANSIONS, JANUARY 2022–MAY 2025 215 TABLE 179 DELOITTE: COMPANY OVERVIEW 216 TABLE 180 DELOITTE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 216 TABLE 181 DELOITTE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 217 TABLE 182 DELOITTE: DEALS, JANUARY 2022–MAY 2025 217 TABLE 183 MCKINSEY & COMPANY: COMPANY OVERVIEW 219 TABLE 184 MCKINSEY & COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 219 TABLE 185 MCKINSEY & COMPANY: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 220 TABLE 186 MCKINSEY & COMPANY: DEALS, JANUARY 2022–MAY 2025 221 TABLE 187 BOSTON CONSULTING GROUP: COMPANY OVERVIEW 223 TABLE 188 BOSTON CONSULTING GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 223 TABLE 189 BOSTON CONSULTING GROUP: DEALS, JANUARY 2022– MAY 2025 224 TABLE 190 PWC: COMPANY OVERVIEW 226 TABLE 191 PWC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 226 TABLE 192 PWC: DEALS, JANUARY 2022–MAY 2025 227 TABLE 193 EY: COMPANY OVERVIEW 228 TABLE 194 EY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 228 TABLE 195 EY: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025 229 TABLE 196 HURON CONSULTING GROUP INC.: COMPANY OVERVIEW 230 TABLE 197 HURON CONSULTING GROUP INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 231 TABLE 198 HURON CONSULTING GROUP INC.: DEALS, JANUARY 2022– MAY 2025 232 TABLE 199 KPMG: COMPANY OVERVIEW 233 TABLE 200 KPMG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 234 TABLE 201 KPMG: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025 236 TABLE 202 KPMG: DEALS, JANUARY 2022– MAY 2025 237 TABLE 203 BAIN & COMPANY, INC.: COMPANY OVERVIEW 238 TABLE 204 BAIN & COMPANY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 238 TABLE 205 BAIN & COMPANY, INC.: DEALS, JANUARY 2022– MAY 2025 239 TABLE 206 IQVIA INC.: COMPANY OVERVIEW 241 TABLE 207 IQVIA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 242 TABLE 208 IQVIA, INC.: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025 244 TABLE 209 IQVIA, INC.: DEALS, JANUARY 2022– MAY 2025 244 TABLE 210 L.E.K CONSULTING: COMPANY OVERVIEW 246 TABLE 211 L.E.K CONSULTING: PRODUCTS/SERVICES/SOLUTIONS OFFERED 246 TABLE 212 L.E.K. CONSULTING: DEALS, JANUARY 2022–MAY 2025 247 TABLE 213 L.E.K CONSULTING: EXPANSIONS, JANUARY 2022–MAY 2025 248 TABLE 214 NTT DATA, INC.: COMPANY OVERVIEW 249 TABLE 215 NTT DATA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 250 TABLE 216 NTT DATA, INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 251 TABLE 217 NTT DATA, INC.: DEALS, JANUARY 2022–MAY 2025 251 TABLE 218 OLIVER WYMAN, LLC: COMPANY OVERVIEW 253 TABLE 219 OLIVER WYMAN, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 253 TABLE 220 OLIVER WYMAN, LLC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 254 TABLE 221 OLIVER WYMAN, LLC: DEALS, JANUARY 2022–MAY 2025 255 TABLE 222 SIMON-KUCHER & PARTNERS: COMPANY OVERVIEW 256 TABLE 223 SIMON-KUCHER & PARTNERS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 256 TABLE 224 IBM: COMPANY OVERVIEW 258 TABLE 225 IBM: PRODUCTS/SERVICES/SOLUTIONS OFFERED 259 TABLE 226 IBM: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 261 TABLE 227 IBM: DEALS, JANUARY 2022–MAY 2025 262 TABLE 228 CLEARVIEW HEALTHCARE PARTNERS: COMPANY OVERVIEW 263 TABLE 229 CLEARVIEW HEALTHCARE PARTNERS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 263 TABLE 230 CLEARVIEW HEALTHCARE PARTNER: OTHER DEALS, JANUARY 2022–MAY 2025 264 TABLE 231 ALVAREZ & MARSAL HOLDINGS, LLC: COMPANY OVERVIEW 265 TABLE 232 ALVAREZ & MARSAL HOLDINGS, LLC: PRODUCTS OFFERED 265 TABLE 233 ALVAREZ & MARSAL HOLDINGS, LLC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2024 266 TABLE 234 ZS ASSOCIATES: COMPANY OVERVIEW 267 TABLE 235 ZS ASSOCIATES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 267 TABLE 236 ZS ASSOCIATES: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 268 TABLE 237 ZS ASSOCIATES: DEALS, JANUARY 2022–MAY 2025 269 TABLE 238 CHARTIS: COMPANY OVERVIEW 270 TABLE 239 CHARTIS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 270 TABLE 240 CHARTIS: DEALS, JANUARY 2022–MAY 2025 271 TABLE 241 QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED: COMPANY OVERVIEW 272 TABLE 242 LUCID HEALTH CONSULTING: COMPANY OVERVIEW 273 TABLE 243 BLUE MATTER CONSULTING: COMPANY OVERVIEW 274 TABLE 244 ISOS CONSULTANCY SERVICES PVT. LTD.: COMPANY OVERVIEW 275 TABLE 245 BACK BAY LIFE SCIENCE ADVISORS: COMPANY OVERVIEW 276 FIGURE 1 HEALTHCARE CONSULTING SERVICES MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 RESEARCH DESIGN 30 FIGURE 3 PRIMARY SOURCES 32 FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 34 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34 FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35 FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION 37 FIGURE 8 HEALTHCARE CONSULTING SERVICES MARKET: REVENUE ESTIMATION APPROACH 37 FIGURE 9 BOTTOM-UP APPROACH: COLLECTIVE REVENUE OF ALL SERVICES/SOLUTIONS OF VENDORS 39 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2030 41 FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41 FIGURE 12 TOP-DOWN APPROACH 42 FIGURE 13 DATA TRIANGULATION METHODOLOGY 43 FIGURE 14 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2025 VS. 2030 (USD MILLION) 46 FIGURE 15 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47 FIGURE 16 GEOGRAPHIC SNAPSHOT OF HEALTHCARE CONSULTING SERVICES MARKET 48 FIGURE 17 GROWING ADOPTION OF HEALTHCARE IT SOLUTIONS TO DRIVE MARKET 49 FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT AND JAPAN LED ASIA PACIFIC MARKET IN 2024 50 FIGURE 19 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51 FIGURE 20 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD 51 FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 52 FIGURE 22 HEALTHCARE CONSULTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53 FIGURE 23 MEDIAN HEALTHCARE DATA BREACH IN US, 2009–2024 59 FIGURE 24 NEW REVENUE POCKETS FOR PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET 65 FIGURE 25 HEALTHCARE CONSULTING SERVICES MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 26 HEALTHCARE CONSULTING SERVICES MARKET: ECOSYSTEM ANALYSIS 68 FIGURE 27 INVESTMENT AND FUNDING SCENARIO, 2019–2024 70 FIGURE 28 HEALTHCARE CONSULTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 82 FIGURE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 84 FIGURE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS 85 FIGURE 31 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT 124 FIGURE 32 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT 154 FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET, 2020–2024 (USD MILLION) 190 FIGURE 34 HEALTHCARE CONSULTING SERVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 191 FIGURE 35 EV/EBITDA OF KEY VENDORS, 2024 193 FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF HEALTHCARE CONSULTING SERVICES VENDORS, 2024 193 FIGURE 37 HEALTHCARE CONSULTING SERVICES MARKET: BRAND/SOFTWARE COMPARISON 194 FIGURE 38 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 196 FIGURE 39 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY FOOTPRINT (KEY PLAYERS), 2024 197 FIGURE 40 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 202 FIGURE 41 ACCENTURE: COMPANY SNAPSHOT (2024) 208 FIGURE 42 COGNIZANT: COMPANY SNAPSHOT (2024) 213 FIGURE 43 HURON CONSULTING GROUP INC.: COMPANY SNAPSHOT (2024) 230 FIGURE 44 KPMG: COMPANY SNAPSHOT (2024) 234 FIGURE 45 IQVIA, INC.: COMPANY SNAPSHOT (2024) 242 FIGURE 46 NTT DATA, INC.: COMPANY SNAPSHOT (2024) 249 FIGURE 47 IBM: COMPANY SNAPSHOT (2024) 259 FIGURE 1 HEALTHCARE CONSULTING SERVICES MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 RESEARCH DESIGN 30 FIGURE 3 PRIMARY SOURCES 32 FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 34 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34 FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35 FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION 37 FIGURE 8 HEALTHCARE CONSULTING SERVICES MARKET: REVENUE ESTIMATION APPROACH 37 FIGURE 9 BOTTOM-UP APPROACH: COLLECTIVE REVENUE OF ALL SERVICES/SOLUTIONS OF VENDORS 39 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2030 41 FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41 FIGURE 12 TOP-DOWN APPROACH 42 FIGURE 13 DATA TRIANGULATION METHODOLOGY 43 FIGURE 14 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2025 VS. 2030 (USD MILLION) 46 FIGURE 15 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47 FIGURE 16 GEOGRAPHIC SNAPSHOT OF HEALTHCARE CONSULTING SERVICES MARKET 48 FIGURE 17 GROWING ADOPTION OF HEALTHCARE IT SOLUTIONS TO DRIVE MARKET 49 FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT AND JAPAN LED ASIA PACIFIC MARKET IN 2024 50 FIGURE 19 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51 FIGURE 20 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD 51 FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 52 FIGURE 22 HEALTHCARE CONSULTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53 FIGURE 23 MEDIAN HEALTHCARE DATA BREACH IN US, 2009–2024 59 FIGURE 24 NEW REVENUE POCKETS FOR PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET 65 FIGURE 25 HEALTHCARE CONSULTING SERVICES MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 26 HEALTHCARE CONSULTING SERVICES MARKET: ECOSYSTEM ANALYSIS 68 FIGURE 27 INVESTMENT AND FUNDING SCENARIO, 2019–2024 70 FIGURE 28 HEALTHCARE CONSULTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 82 FIGURE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 84 FIGURE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS 85 FIGURE 31 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT 124 FIGURE 32 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT 154 FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET, 2020–2024 (USD MILLION) 190 FIGURE 34 HEALTHCARE CONSULTING SERVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 191 FIGURE 35 EV/EBITDA OF KEY VENDORS, 2024 193 FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF HEALTHCARE CONSULTING SERVICES VENDORS, 2024 193 FIGURE 37 HEALTHCARE CONSULTING SERVICES MARKET: BRAND/SOFTWARE COMPARISON 194 FIGURE 38 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 196 FIGURE 39 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY FOOTPRINT (KEY PLAYERS), 2024 197 FIGURE 40 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 202 FIGURE 41 ACCENTURE: COMPANY SNAPSHOT (2024) 208 FIGURE 42 COGNIZANT: COMPANY SNAPSHOT (2024) 213 FIGURE 43 HURON CONSULTING GROUP INC.: COMPANY SNAPSHOT (2024) 230 FIGURE 44 KPMG: COMPANY SNAPSHOT (2024) 234 FIGURE 45 IQVIA, INC.: COMPANY SNAPSHOT (2024) 242 FIGURE 46 NTT DATA, INC.: COMPANY SNAPSHOT (2024) 249 FIGURE 47 IBM: COMPANY SNAPSHOT (2024) 259